Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium
- PMID: 19586082
- DOI: 10.2165/00019053-200927050-00008
Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium
Comment on
-
Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium.Pharmacoeconomics. 2009;27(3):231-45. doi: 10.2165/00019053-200927030-00006. Pharmacoeconomics. 2009. PMID: 19354343
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
